Inactive Instrument
Sector dividends Orexigen Therapeutics Nasdaq
Stocks
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1.43% | 1.57% | 20.78x | 4.9x | 7.37x | 14.79x | 16.73x | 70.88B | |
| 0.04% | 0.08% | 32.47x | 6.41x | 9.38x | 45.35x | 29.77x | 62.49B | |
| -.--% | -.--% | -73.25x | 36.76x | 14.16x | -68.28x | -81.78x | 26.21B | |
| -.--% | -.--% | 30.44x | 3.2x | 6.47x | 16.8x | 20.15x | 26.34B | |
| -.--% | -.--% | -14.7x | 1.2x | 5.35x | -6.73x | -5.31x | 24.13B | |
| -.--% | -.--% | 28.25x | 3.37x | 5.33x | 17.72x | 19.86x | 20.72B | |
| 0.34% | 0.2% | 44.51x | 11.08x | 16.33x | 33.12x | 35.77x | 15.36B | |
| -.--% | -.--% | 18.03x | 5.55x | 5.37x | 12.55x | 13.3x | 14.46B | |
| -.--% | -.--% | -15.41x | 52.75x | 3483.86x | -17.81x | -15.3x | 14.25B | |
| -.--% | -.--% | 1004.05x | 16.29x | 35.03x | 605.09x | -226.66x | 14.06B | |
| -.--% | -.--% | -84.18x | 27.36x | 7.7x | -63.79x | -62.44x | 12.28B | |
| -.--% | 0.01% | -322.3x | 7.93x | 14.33x | 893.9x | -283.13x | 10.63B | |
| -.--% | -.--% | -11.23x | -72.1x | 56.09x | -11.7x | -11.48x | 9.56B | |
| -.--% | -.--% | -18.26x | 24.11x | 18.56x | -20.18x | -17.93x | 9.39B | |
| -.--% | -.--% | -6.94x | - | - | -7.19x | -6.65x | 8.65B | |
| -.--% | -.--% | -30.84x | 8.11x | - | -27.13x | -28x | 7.96B | |
| -.--% | -.--% | 8.13x | 4.5x | 6.71x | 10.9x | 11.86x | 8.04B | |
| Average | 0.11% | 0.11% | 35.86x | 8.84x | 246.14x | 83.97x | -34.78x | 20.91B | |
| Weighted average by Cap. | 0.31% | 0.34% | 35.12x | 9.18x | 157.50x | 56.02x | -14.59x |
- Stock Market
- Stocks
- Stock
- Stock
- Sector Orexigen Therapeutics
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
